1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
610F5F78311DACC9E00258BB100776091
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew?OpenForm&Query=(medical+affairs)+and+(field+ItemCatalog=BMR)&SearchWV=1&sort=relevance&Start=1&Count=10
18
19OpenForm&Query=(medical+affairs)+and+(field+ItemCatalog=BMR)&SearchWV=1&sort=relevance&Start=1&Count=10
203.238.82.77
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Search Results

Results 1 - 10 of 248 Total Hits, Sorted by Relevance.

    |    

Building More Effective Medical Affairs Product Launch Teams: Infectious Diseases SegmentDirect access to this research is not included with your membership level.

Medical Affairs teams need to be agile and responsive in launching infectious disease treatments that meet evolving population health needs or public health crises... (ID POP-389)
Companies Profiled: AstraZeneca, bioMerieux, Boehringer Ingelheim, Cardinal Health, more ...

Building More Effective Medical Affairs Product Launch Teams: Respiratory SegmentDirect access to this research is not included with your membership level.

Medical Affairs teams play a crucial role in supporting respiratory product launches, ensuring that new treatments are effectively positioned and com... (ID POP-392)
Companies Profiled: AstraZeneca, BELLUS Health, BIAL, bioMerieux, more ...

Building More Effective Medical Affairs Product Launch Teams: Oncology SegmentDirect access to this research is not included with your membership level.

Oncology is the most competitive and rapidly advancing therapeutic area in healthcare, where Medical Affairs teams play a pivotal role in ensuring that new treatments reach patients effectively... (ID POP-391)
Companies Profiled: AstraZeneca, Boehringer Ingelheim, Eisai, EMD Serono, more ...

Building More Effective Medical Affairs Product Launch Teams: Metabolic Diseases SegmentDirect access to this research is not included with your membership level.

Given the chronic nature of metabolic diseases, Medical Affairs teams play a critical role in shaping product launch strategies that extend beyond cl... (ID POP-390)
Companies Profiled: AstraZeneca, BIAL, Boehringer Ingelheim, Cipla, more ...

Building More Effective Medical Affairs Product Launch Teams: Immunology SegmentDirect access to this research is not included with your membership level.

In the dynamic field of immunology, Medical Affairs teams are central to orchestrating successful product launches, navigating the complex interplay ... (ID POP-388)
Companies Profiled: AstraZeneca, ASC Therapeutics, Boehringer Ingelheim, Duke University and Health System, more ...

Building More Effective Medical Affairs Product Launch Teams: Hematology SegmentDirect access to this research is not included with your membership level.

As hematology treatments proliferate, the strategic involvement of Medical Affairs is crucial for successful product launches... (ID POP-387)
Companies Profiled: Apellis Pharmaceuticals, ASC Therapeutics, AstraZeneca, Duke University and Health System, more ...

Building More Effective Medical Affairs Product Launch Teams: CNS / Neurosciences SegmentDirect access to this research is not included with your membership level.

Medical Affairs plays a pivotal role in the rapidly growing and transforming CNS market, where product launches demand innovative and high-impact strategies... (ID POP-386)
Companies Profiled: Adamas Pharmaceuticals, Apellis Pharmaceuticals, AstraZeneca, BELLUS Health, more ...

Building More Effective Medical Affairs Product Launch Teams: Cardiology and Pulmonology SegmentDirect access to this research is not included with your membership level.

In the large, competitive fields of Cardiology and Pulmonology, Medical Affairs teams are increasingly pivotal in the differentiation and successful launch of new products... (ID POP-385)
Companies Profiled: AstraZeneca, BIAL, bioMerieux, Boehringer Ingelheim, more ...

Assessing the Impact of Medical Affairs: Embrace New Measurement Strategies to Promote Your Value Story, Increase Impact, and Gain ResourcesDirect access to this research is not included with your membership level.

As the demands on Medical Affairs teams continue to grow, demonstrating value and ensuring adequate investment requires focusing on measurable outcomes which align with overall business success... (ID POP-394)
Companies Profiled: AbbVie, Alkermes, Astellas, AstraZeneca, more ...

Medical’s Road Map for Social Media Success in Rare Disease SegmentDirect access to this research is not included with your membership level.

With such a small patient population, Medical Affairs groups within Rare Disease organizations often find it difficult to establish meaningful connections... (ID POP-361)
Companies Profiled: AbbVie, Avidity Biosciences, AstraZeneca, Baxter Healthcare, more ...